Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

OMEGA-3 ETHYL ESTERS 1 GM CAP

Omega-3-acid ethyl esters
$0.1926per EA
High Outlier

Strength

900 mg/1

Manufacturer

Par Pharmaceutical Inc.

NDC

00254301008

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Last Updated

9/22/2021

Active Ingredients

OMEGA-3-ACID ETHYL ESTERS

Approval Type

Generic (ANDA)

FDA Application

ANDA203893

On Market Since

9/19/2017

Pharmacological Classes

Fatty Acids
Omega-3
Omega-3 Fatty Acid

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

+5.2%

All

-26.9%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

OMEGA-3 ETHYL ESTERS 1 GM CAP
Generic
00904749506•Major Pharmaceuticals
$0.1715
per EA
OMEGA-3 ETHYL ESTERS 1 GM CAP
Generic
24658035012•PuraCap Laboratories LLC
$0.1715
per EA
OMEGA-3 ETHYL ESTERS 1 GM CAP
Generic
42806055212•Epic Pharma LLC
$0.1715
per EA
OMEGA-3 ETHYL ESTERS 1 GM CAP
Generic
60687084665•American Health Packaging
$0.1715
per EA
OMEGA-3 ETHYL ESTERS 1 GM CAP
Generic
62135078012•Chartwell RX LLC
$0.1715
per EA
OMEGA-3 ETHYL ESTERS 1 GM CAP
Generic
64380076111•Strides Pharma Inc.
$0.1715
per EA
OMEGA-3 ETHYL ESTERS 1 GM CAP
Generic
65162003416•Amneal Pharmaceuticals LLC
$0.1715
per EA
OMEGA-3 ETHYL ESTERS 1 GM CAP
Generic
69452017522•Bionpharma Inc.
$0.1715
per EA
OMEGA-3 ETHYL ESTERS 1 GM CAP
Generic
70756042322•Lifestar Pharma LLC
$0.1715
per EA
BP VIT 3 CAPSULE
Generic
42192030160•Acella Pharmaceuticals, LLC
$0.7268
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy